Eupraxia Pharmaceuticals Income Statement (2022-2026) | EPRX

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 21.59M21.70M22.01M25.52M27.28M28.81M35.62M35.62M35.64M35.69M35.91M36.92M39.96M56.71M
Revenue & cost
Revenue (Quarter) -0.13M0.86M0.36M
Operating items
Research & Development (Quarter) 2.27M4.76M9.54M4.18M4.05M3.97M3.85M5.20M4.42M7.87M11.17M
Wages, Salaries and Other (Quarter) 1.39M1.46M1.42M1.66M1.71M1.79M3.10M
Selling, General & Administrative (Quarter) 1.26M1.86M2.44M2.52M2.22M3.60M3.27M3.07M2.47M8.30M4.78M
Restructuring Costs (Quarter) 1.84M1.12M1.42M1.44M1.59M1.49M1.94M
Other Operating Expenses (Quarter) -0.31M-3.65M1.88M2.08M0.77M0.43M0.03M-0.00M0.00M-0.00M-1.94M
Operating Expenses (Quarter) 3.54M5.71M6.62M11.98M6.69M6.56M6.27M7.48M7.12M8.26M6.88M16.16M15.96M
EBIT (Quarter) -4.25M-6.47M-5.99M-6.32M-6.76M-8.74M-6.37M-16.69M-12.64M
Non-operating items
Interest & Investment Income (Quarter) 0.16M0.15M0.19M0.35M0.24M0.40M0.30M0.22M0.31M0.26M0.18M0.67M1.07M
Other Non Operating Income (Quarter) 0.02M0.01M-0.03M0.06M-0.14M-0.08M0.12M-0.07M0.05M-0.73M-0.51M-2.43M2.24M
Non Operating Income (Quarter) 1.73M1.41M0.28M-0.05M0.36M-0.48M0.51M-0.55M3.32M
Net income details
EBT (Quarter) -3.96M-6.15M-5.99M-7.53M-6.76M-8.74M-6.37M-16.71M-12.64M
Tax Provisions (Quarter) -0.01M0.01M-0.00M-0.01M-0.01M
Profit After Tax (Quarter) 3.96M9.51M-4.90M-46.58M6.16M6.06M-5.99M-7.72M6.77M8.75M6.37M-16.72M12.65M
Investment Income (Quarter) -0.01M-0.03M
Income from Non-Controlling Interests (Quarter) -0.06M-0.13M-0.17M-0.38M-0.11M-0.06M-0.05M-0.02M-0.00M-0.01M-0.01M-0.01M-0.00M
Income from Continuing Operations (Quarter) -3.96M-6.15M-5.99M-7.53M-6.76M-8.74M-6.37M-16.71M-12.63M
Consolidated Net Income (Quarter) -3.96M-6.15M-5.99M-7.53M-6.76M-8.74M-6.37M-16.71M-12.63M
Income towards Parent Company (Quarter) 3.90M-9.38M-4.72M-6.04M-6.01M5.94M-7.53M6.76M8.74M6.36M-16.71M12.65M
Net Income towards Common Stockholders (Quarter) -3.96M-9.51M-4.90M-6.16M-6.06M-5.99M-7.53M-6.77M-8.75M-6.37M-16.71M-12.65M
Additional items
EPS (Basic) (Quarter) -0.18-0.43-0.19-0.21-0.17-0.17-0.22-0.19-0.24-0.17-0.42-0.22
EPS (Diluted) (Quarter) -0.21-0.49-0.25-0.25-0.25-0.25-0.22-0.20-0.26-0.19-0.42-0.32
Shares Outstanding (Quarter) 19.29M21.70M22.01M25.52M24.15M28.81M35.62M35.62M33.93M35.69M35.91M36.92M39.96M56.71M
Shares Outstanding (Diluted) (Quarter) 19.29M19.29M19.29M19.29M24.15M24.15M24.15M24.15M33.93M33.93M33.93M33.93M39.96M39.96M
EBITDA (Quarter) -4.25M-6.47M-5.99M-6.32M-6.76M-8.74M-6.37M-16.69M-12.64M
Interest Expenses (Quarter) 17.15M-0.29M-0.30M-0.32M2.08M-0.32M-0.28M-451.001.21M0.02M
Tax Rate (Quarter) 0.080.040.060.11